Annals of the Rheumatic Diseases · 2022 · 10 citations · 0 references
MedicineInternal MedicinePharmacologyClinical PharmacologyPharmacovigilanceRheumatologyAutoimmune Rheumatic DiseasesCardiovascular DiseaseCardiovascular Drug SafetyCardiovascular PharmacologyInflammatory ArthritisRheumatoid ArthritisAdverse Cardiovascular Drug EventsBiologic EfficacyClinical Trial Safety SurveillanceConventional Synthetic Disease-modifying Antirheumatic DrugsJak Inhibitor TherapyJanus Kinase Inhibitor TherapyRheumatoid Arthritis PharmacotherapyRheumatoid Arthritis Therapy